Medical Rationale
Chronic hypertension is the second most common cause of end-stage renal disease in the United States after diabetes. Sustained elevated blood pressure causes hypertensive nephrosclerosis — arteriolar thickening, glomerular ischemia, tubular atrophy, and progressive interstitial fibrosis. The afferent arteriolar vasoconstriction and glomerular ischemia from hypertension produce nephron loss and declining GFR. Hypertensive nephrosclerosis is histologically characterized by arteriolar hyalinosis and global glomerulosclerosis on biopsy. African-American veterans are particularly vulnerable to hypertensive nephrosclerosis due to APOL1 gene variants that confer increased susceptibility.
Key Studies
Klag MJ et al. (1996) N Engl J Med (blood pressure and ESRD risk); Freedman BI et al. (2009) Kidney Int (hypertensive nephrosclerosis); Appel LJ et al. (2010) Clin J Am Soc Nephrol (CKD and BP management).
Filing Tips
Serial creatinine and eGFR records documenting declining renal function over time. Urine ACR demonstrating proteinuria. Renal ultrasound showing bilateral kidney scarring or size reduction. Nephrology records. The nexus is established by documenting hypertension predating and correlating temporally with CKD onset.